alexa Potential Anticancer Activity Of The Fruit Peels Of Solanum Melongena L. Against Hepatocellular Carcinoma In Vitro And In Vivo
ISSN: 1948-5956

Journal of Cancer Science & Therapy
Open Access

Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Share This Page

Additional Info

Loading
Loading Please wait..
 

3rd World Congress on Cancer Science & Therapy
October 21-23, 2013 DoubleTree by Hilton Hotel San Francisco Airport, CA, USA

Shahira M. Ezzat, M. M. Shabana, M. M. Salama and L. A. Rashad
Posters: J Cancer Sci Ther
DOI: 10.4172/1948-5956.S1.029
Abstract
Solanum melongena L. is one of the most common and important vegetables in the world. Peel is the major byproduct of its fruits and in many cases it is being wasted. The peels of the fruits of Solanum melongena L. were extracted using methanol in an approach to search for bioactive conserves in such waste products. Fractionation and purification of the methanol extract of the peels (MEP) yielded five steroidal compounds; three steroidal alkaloids: solasodine (1), solamargine (4) and solasonine (5) together with two steroidal glycosides; β-sitosterol-3-O-β-D-glucoside (2) and poriferasterol-3-O-β-D-glucoside (3) were isolated. Identification of the aforementioned compounds was carried out on the basis of physico-chemical properties and spectral analysis ( 1 H-NMR, 1 H- 1 H COSY, 13 C-NMR and HMBC). MEP together with the isolated compounds were tested against five human cancer cell lines representing the most common types of cancer in Egypt; colon cancer cell line (HCT116), larynx cancer cell line (HEP2), breast cancer cell line (MCF7), cervix cancer cell line (HELA) and hepatocellular carcinoma (HEPG2). MEP, solasodine and solamargine showed significant activities against the five tested human cancer cell lines, however their pronounced cytotoxic activity was noticeable and obvious against the hepatocellular carcinoma (HEPG2). Consequently, MEP (IC 50 2.14 ? 0.35) was tested in vivo against hepatocellular carcinoma with the aim of confirming its anticancer activity. MEP showed a dose dependent anticancer activity through stabilization of the hepato-cells verified by reduction in α-fitorotein (AFP) which is considered a liver tumor indicator (30.98 % at 100 mg/kg b wt and 45.77% at 200 mg/kg b wt), in addition it also restored the levels of AST (35.97 % at 100 and 48.78 % at 200 mg/kg b wt), ALT (31.22 % at 100 and 43.16 % at 200 mg/kg b wt) and albumin (26.42 at 100 and 47.64 % at 200 mg/kg b wt) in a dose dependent manner. Histopathology of liver tissues treated with MEP showed also normal liver cells, normal portal tracts and absence of fibrosis and inflammation. Our findings showed that MEP which is a source of steroidal alkaloids and sterol glycosides exhibited potential anticancer activity against hepatocellular carcinoma- in vitro and in vivo -and this supports the reuse of waste products as it could be a source of a new remedy for treating major diseases. Keywords: Solanum melongena L., peels, anticancer, solasodine, solamargine, solasonine.
image PDF   |   image HTML
 

Relevant Topics

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri, Food, Aqua and Veterinary Science Journals

Dr. Krish

[email protected]

1-702-714-7001 Extn: 9040

Clinical and Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

[email protected]

1-702-714-7001Extn: 9042

Chemical Engineering and Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001 Extn: 9040

Earth & Environmental Sciences

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

General Science and Health care Journals

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics and Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001 Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Informatics Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Material Sciences Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Mathematics and Physics Journals

Jim Willison

[email protected]

1-702-714-7001 Extn: 9042

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001 Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

John Behannon

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001 Extn: 9042

 
© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords